DT
PDLI

Diversified Trust’s PDL BioPharma, Inc. PDLI Stock Holding History

Diversified Trust’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.7K Hold
11,554
– – ﹤0.01% 1103
2026
Q1 		$27.7K Buy
11,554
+525
+5% +$1.26K ﹤0.01% 1037
2025
Q4 		$26.5K Hold
11,029
– – ﹤0.01% 1027
2025
Q3 		$26.5K Hold
11,029
– – ﹤0.01% 985
2025
Q2 		$26.5K Hold
11,029
– – ﹤0.01% 924
2025
Q1 		$26.5K Hold
11,029
– – ﹤0.01% 909
2024
Q4 		$26.5K Hold
11,029
– – ﹤0.01% 911
2024
Q3 		$26.5K Hold
11,029
– – ﹤0.01% 897
2024
Q2 		$26.5K Hold
11,029
– – ﹤0.01% 860
2024
Q1 		$26.5K Hold
11,029
– – ﹤0.01% 817
2023
Q4 		$26.5K Hold
11,029
– – ﹤0.01% 857
2023
Q3 		$26.5K Hold
11,029
– – ﹤0.01% 815
2023
Q2 		$26.5K Hold
11,029
– – ﹤0.01% 818
2023
Q1 		$26.5K Buy
+11,029
New +$26.5K ﹤0.01% 807

Other funds holding PDLI

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Diversified Trust's PDLI Position: Q2 2026 in Review

Diversified Trust held its PDL BioPharma, Inc. (PDLI) position steady in Q2 2026 at 11,554 shares worth $27.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1103.

Diversified Trust first reported a position in PDLI in Q1 2023 and has held it in 14 quarters since. 5 funds tracked by Wall St. Rank hold PDLI as of Q2 2026.

  • Diversified Trust held 11,554 shares of PDL BioPharma, Inc. worth $27.7K as of Q2 2026.
  • Diversified Trust left its PDL BioPharma, Inc. share count unchanged in Q2 2026.
  • PDL BioPharma, Inc. made up ﹤0.01% of Diversified Trust's portfolio in Q2 2026, its #1103 holding.
  • Diversified Trust first reported a position in PDL BioPharma, Inc. in Q1 2023 and has held it in 14 quarters since.
  • 5 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.